Xeris Pharmaceuticals
XERS
#6076
Rank
A$1.12 B
Marketcap
$7.29
Share price
-9.63%
Change (1 day)
134.40%
Change (1 year)

Earnings for Xeris Pharmaceuticals (XERS)

Earnings in 2024 (TTM): -A$39.4 Million

According to Xeris Pharmaceuticals's latest financial reports the company's current earnings are A$0.20 Billion. , an increase over its 2023 earnings that were of -A$61.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xeris Pharmaceuticals from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -A$44.03 Million-27.85%
2023 -A$61.03 Million-54.31%
2022 -A$0.14 Billion-30.11%
2021 -A$0.2 Billion43.37%
2020 -A$0.14 Billion-32.21%
2019 -A$0.2 Billion106.61%
2018 -A$95.17 Million116.69%
2017 -A$43.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion 436.82%๐Ÿ‡บ๐Ÿ‡ธ USA